Accessibility Menu
Smith & Nephew Plc logo

Smith & Nephew Plc(OTC) SNNUF

Current Price$15.10
Market Cap$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+172%
5 Year-19%
1 Year+4%
1 Month+15%
Smith & Nephew Plc last closing stock price
MetricPriceDate
Last closeUSD 15.102026-07-24
Smith & Nephew Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.02%USD 14.112026-07-17
1 month+15.27%USD 13.102026-06-23
3 month-6.67%USD 16.182026-04-23
Year to date-7.12%USD 16.262025-12-31
1 year+3.5%USD 14.592025-07-24
3 year+10.09%USD 13.722023-07-25
5 year-19.19%USD 18.692021-07-22
Since inception+171.55%USD 5.562003-06-26

Smith & Nephew Plc Financials at a Glance

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$12.11B

Net Income (TTM)

$1.04B

EPS (TTM)

$0.72

P/E Ratio

20.95

Dividend

$0.39

Beta (Volatility)

0.12 (Low)

Price

$15.10

Volume

238

Open

$15.00

Previous Close

$15.10

Daily Range

$15.00 - $15.10

52-Week Range

$13.10 - $18.50

Estimated Earnings Date

Aug 4, 2026

SNNUF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Smith & Nephew Plc

Smith & Nephew plc is a global medical technology enterprise focused on developing, manufacturing, and commercializing a wide range of medical devices. The company operates in key areas such as orthopedics, sports medicine, and advanced wound management, providing innovative solutions to healthcare providers worldwide.

Products and Services
  • Knee and hip implants for orthopedic procedures
  • Joint repair solutions and arthroscopic enabling technologies
  • Advanced wound management products for chronic and acute wounds
Growth Outlook
  • Revenue of $3.34 billion in Q4 2025, showing strong demand
  • Net income of $345.9 million in Q4 2025, reflecting profitability
  • Consistent investment in R&D, with $159.6 million in Q4 2025
Financial Highlights
  • Trailing twelve months (TTM) revenue of $12.5 billion, indicating robust performance
  • Dividend yield of 2.55%, appealing for income-focused investors
  • Operating income margin of 17.8% in Q4 2025, showcasing operational efficiency
Smith & Nephew plc has established itself as a leader in the medical devices industry, with a diverse product portfolio that addresses critical healthcare needs. The company's commitment to innovation and quality positions it well for future growth, supported by strong financial performance and a focus on research and development. With a solid dividend yield and consistent revenue growth, Smith & Nephew presents an attractive opportunity for potential investors interested in the healthcare sector.
AI Generated • Jul 13, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

18,362

CEO

Deepak S Nath, PhD

Website

www.smith-nephew.com

Headquarters

Watford, HR WD18 8YE, GB

SNNUF Financials

Key Financial Metrics (TTM)

Gross Margin

68.01%

Operating Margin

16.27%

Net Income Margin

10.14%

Return on Equity

11.79%

Return on Capital

12.53%

Return on Assets

6.10%

Earnings Yield

4.77%

Dividend Yield

2.57%

Payout Ratio

52.80%

Stock Overview

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

841.18M

Volume

238

Avg. Volume

1.91K

Financials (TTM)

Gross Profit

$8.27B

Operating Income

$1.82B

EBITDA

$2.91B

Operating Cash Flow

$2.27B

Capital Expenditure

-$813.71M

Free Cash Flow

$1.46B

Cash & ST Invst.

$557.89M

Total Debt

$3.33B

Smith & Nephew Plc Performance Analysis

Smith & Nephew Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 5,215,000,0000.1%
20232023-12-31USD 5,549,000,0006.4%
20242024-12-31USD 5,810,000,0004.7%
20252025-12-31USD 6,164,000,0006.1%
Smith & Nephew Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-300.4%
Q42024-12-315.5%
Q22025-06-28-0.7%
Q42025-12-3112.8%
Smith & Nephew Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.26-57.2%
20232023-12-31USD 0.3018.0%
20242024-12-31USD 0.4756.1%
20252025-12-31USD 0.7252.2%
Smith & Nephew Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30127.3%
Q42024-12-31-12.0%
Q22025-06-2850.0%
Q42025-12-3121.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$3.34B

+18.7%

Gross Profit

$2.19B

+12.4%

Gross Margin

65.69%

N/A

Market Cap

$12.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$732.14K

N/A

Employees

17,349

N/A

Net Income

$345.90M

+274.1%

EBITDA

$909.05M

+62.1%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$557.89M

+84.7%

Total Debt

$3.33B

+8.1%

Accounts Receivable

$1.43B

+35.2%

Inventory

$2.12B

-11.5%

Long Term Debt

$3.18B

+37.2%

Short Term Debt

$150.00M

-80.4%

Return on Assets

6.10%

N/A

Return on Invested Capital

11.55%

N/A

Free Cash Flow

$613.95M

+156.2%

Operating Cash Flow

$917.58M

+83.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
FMCQFFresenius Medical Care AG
$48.85+0.00%
GIKLYGrifols, S.A.
$5.10+0.00%
SBMFFSino Biopharmaceutical Limited
$0.64+0.00%
SONVYSonova Holding AG
$51.51+0.78%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Questions About SNNUF

What is the current price of Smith & Nephew Plc?

Smith & Nephew Plc is trading at $15.10 per share.

What is the 52-week range for Smith & Nephew Plc?

Over the past 52 weeks, Smith & Nephew Plc has traded between $13.10 and $18.50.

How much debt does Smith & Nephew Plc have?

As of the most recent reporting period, Smith & Nephew Plc reported total debt of $3.33B.

How much cash does Smith & Nephew Plc have on hand?

Smith & Nephew Plc reported $557.00M in cash and cash equivalents in its most recent financial results.

What is Smith & Nephew Plc’s dividend yield?

Smith & Nephew Plc currently has a dividend yield of 2.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services